Anne-Christine Andréasson

4PUBLICATIONS
29CO-AUTHORS
Predictive and prognostic markersMolecular targetsNanometrologyGenetically modified animals
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 03, 2026
Fibroblast activation protein and down-stream effects on its substrates in metabolic dysfunction-associated steatotic liver disease.

|Jan 17, 2023
FGF21 protects against hepatic lipotoxicity and macrophage activation to attenuate fibrogenesis in nonalcoholic steatohepatitis.

Cong Liu, Milena Schönke, Borah Spoorenberg

|Jul 14, 2022
Hepatic patatin-like phospholipase domain-containing 3 levels are increased in I148M risk allele carriers and correlate with NAFLD in humans.

Elke Ericson, Linnéa Bergenholm, Anne-Christine Andréasson

|Apr 06, 2019
The APOE∗3-Leiden Heterozygous Glucokinase Knockout Mouse as Novel Translational Disease Model for Type 2 Diabetes, Dyslipidemia, and Diabetic Atherosclerosis.

Marianne G Pouwer, Suvi E Heinonen, Margareta Behrendt

Pageof 1

Frequent Collaborators

2 joint publications

Mathias Liljeblad

2 joint publications

Mattias Ekstedt

2 joint publications

Patrik Nasr

2 joint publications

Sara F Hansson